Also trades as: INDV.L (LSE) · $vol 5M

$37.53

+0.07 (+0.19%)

Weekly Expected Move ±5.8%

$33 $35 $37 $39 $41

NASDAQ · Healthcare · Drug Manufacturers - Specialty & Generic · Alpha Radar Buy · Power 68 · $4.7B mcap · 116M float · 2.27% daily turnover · Short 54% of daily vol

Revenue Segmentation

By Product / Service

By Geography

Revenue by Segment (5-Year Trend)

Income Trends

Revenue

$1.2B +4.3% ▲

5Y CAGR: +13.9%

Gross Profit

$994M +3.9% ▲

5Y CAGR: +12.6%

Operating Income

$262M +718.8% ▲

Net Income

$210M +10400.0% ▲

EPS (Diluted)

$1.64 +10833.3% ▲

EBITDA

$304M +261.9% ▲

Profit Margins

Year-over-Year Growth

View Full Income Statement

Line Item	FY2021	FY2022	FY2023	FY2024	FY2025
Revenue	$791M	$901M	$1.1B	$1.2B	$1.2B
YoY Growth	+12.7%	+13.8%	+23.6%	+8.7%	+4.3%
Cost of Revenue	$127M	$151M	$174M	$231M	$245M
Gross Profit	$664M	$750M	$919M	$957M	$994M
Gross Margin	83.9%	83.2%	84.1%	80.6%	80.2%
R&D Expenses	$52M	$74M	$116M	$107M	$97M
SG&A Expenses	$431M	$469M	$569M	$618M	$634M
Operating Expenses	$451M	$831M	$1.1B	$925M	$731M
Operating Income	$213M	-$81M	-$156M	$32M	$262M
Operating Margin	26.9%	-9.0%	-14.3%	2.7%	21.1%
Interest Expense	$26M	$29M	$35M	$41M	$45M
Income Before Tax	$190M	-$89M	-$149M	$14M	$239M
Tax Expense	-$15M	-$44M	-$20M	$11M	$29M
Net Income	$205M	-$44M	-$129M	$2M	$210M
Net Margin	25.9%	-4.9%	-11.8%	0.2%	16.9%
EPS (Diluted)	$1.31	$-0.37	$0.01	$0.01	$1.64
EBITDA	$238M	-$46M	-$99M	$84M	$304M
Shares Outstanding	154M	139M	142M	133M	128M

Line Item	FY2024 Q2	FY2024 Q3	FY2024 Q4	FY2025 Q1	FY2025 Q2	FY2025 Q3	FY2025 Q4	FY2026 Q1
Revenue	$299M	$307M	$299M	$266M	$302M	$314M	$358M	$317M
Cost of Revenue	$79M	$69M	$23M	$44M	$52M	$84M	$64M	$40M
Gross Profit	$220M	$238M	$276M	$222M	$250M	$230M	$294M	$277M
Gross Margin	73.6%	77.5%	92.3%	83.5%	82.8%	73.2%	82.1%	87.4%
R&D Expenses	$26M	$22M	$31M	$22M	$21M	$33M	$17M	$16M
SG&A Expenses	$152M	$208M	-$47M	$132M	$158M	$155M	$155M	$124M
Operating Expenses	$338M	$234M	$180M	$156M	$178M	$187M	$172M	$140M
Operating Income	-$118M	$4M	$96M	$66M	$72M	$43M	$122M	$137M
Operating Margin	-39.5%	1.3%	32.1%	24.8%	23.8%	13.7%	34.1%	43.2%
Interest Expense	$9M	$10M	$13M	$12M	$15M	$12M	$6M	$7M
Income Before Tax	-$121M	-$1M	$88M	$59M	$62M	$37M	$81M	$115M
Tax Expense	-$23M	-$5M	$28M	$11M	$44M	-$5M	-$21M	$26M
Net Income	-$97M	$4M	$59M	$47M	$18M	$42M	$102M	$89M
Net Margin	-32.4%	1.3%	19.7%	17.7%	6.0%	13.4%	28.5%	28.1%
EPS (Diluted)	$-0.72	$0.03	$0.45	$0.38	$0.14	$0.33	$0.82	$0.69
EBITDA	-$106M	$22M	$106M	$76M	$82M	$51M	$127M	$139M
Shares Outstanding	135M	134M	128M	124M	124M	129M	125M	129M

INDV NASDAQ